Details of the Drug
General Information of Drug (ID: DMCJI5P)
Drug Name |
N-1177-inh
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-1177; PH-50; WIN-67722; Imaging agent (cancer), IMCOR; Imaging agent (cancer), Photogen; Imaging agent (cardiovascular), IMCOR; Imaging agent (cardiovascular), Photogen; N-1177-iv; N-1177-sq; N-1177-sq); Nanoparticle contrast agent (atherosclerosis), NanoScan Imaging; Nanoparticle contrast agent (cancer), NanoScan Imaging; Nanoparticle contrast agent (pulmonary tumor), NanoScan Imaging; N-1177 (inhaled, lung cancer), NanoScan Imaging; N-1177 (intravenous,atherosclerosis), NanoScan Imaging; N-1177 (subcutaneous,cancer), NanoScan Imaging
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Structure | 3D Structure is Not Available | ||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||